FRUMENTO, GIULIA

FRUMENTO, GIULIA  

100006 - Dipartimento di Farmacia  

Mostra records
Risultati 1 - 9 di 9 (tempo di esecuzione: 0.011 secondi).
Titolo Data di pubblicazione Autore(i) File
A repurposing approach to delay disease progression in SOD1G93A mice by counteracting oligodendrocyte dysfunction 1-gen-2023 Raffaele, S.; Bonifacino, T.; Nguyen, N.; Boccazzi, M.; Frumento, G.; Milanese, M.; Bonanno, G.; Abbracchio, M. P.; Fumagalli., M.
A repurposing approach to improve disease outcome in SOD1G93A mice by counteracting oligodendrocyte dysfunction and neuroinflammation 1-gen-2023 Raffaele, Stefano; Nguyen, Nhung; Boccazzi, Marta; Frumento, Giulia; Milanese, Marco; Mannella, Francesca C.; Lambertsen, Kate L.; Madsen, Kirsten; Schroeder, Henrik D.; Hejbøl, Eva K.; Bonanno, Giambattista; Abbracchio, Maria P.; Bonifacino, Tiziana; Fumagalli, Marta
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex. 1-gen-2021 Sala, N.; Paoli, C.; Bonifacino, T.; Mingardi, J.; Schiavon, E.; La Via, L.; Milanese, M.; Tornese, P.; Datusalia, A. K.; Rosa, J.; Facchinetti, R.; Frumento, G.; Carini, G.; Salerno Scarzella, F.; Forti, L.; Barbon, A.; Bonanno, G.; Popoli, M.; Musazzi, L.
Effects of the in-vivo treatment with the non-selective GPR17 antagonist montelukast on disease outcome in the SOD1G93A mouse model of ALS 1-gen-2023 Bonifacino, T.; Nhung Nguyen, T. P.; Raffaele, S.; Frumento, G.; Milanese, M.; Abbracchio, M. P.; Bonanno, G.; Fumagalli, M.
In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS 1-gen-2021 Milanese, M.; Torazza, C.; Provenzano, F.; Bonifacino, T.; Ravera, S.; Balbi, M.; Frumento, G.; Kumar, M.; Cerminara, M.; Puliti, A.; Usai, C.; Bonanno, G.
In-vivo treatment with the GPR17 antagonist montelukast improves lifespan and delays disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 1-gen-2022 Bonifacino, T.; Nguyen, T. P. N.; Raffaele, S.; Frumento, G.; Milanese, M.; Abbracchio, M. P.; Bonanno, G.; Fumagalli, M.
Montelukast improves disease outcomes in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity 1-gen-2024 Bonifacino, T.; Raffaele, S.; Nguyen, N.; Boccazzi, M.; Frumento, G.; Milanese, M.; Bonanno, G.; Abbracchio, M. P.; Fumagalli, M.
Montelukast improves disease progression in the female SOD1G93A mouse model of ALS by restoring oligodendrocyte maturation and counteracting altered glial reactivity 1-gen-2023 Bonifacino, Tiziana; Raffaele, Stefano; Nguyen, THI PHUONG NHUNG; Marta, Boccazzi; Frumento, Giulia; Milanese, Marco; Bonanno, Giambattista; Abbracchio Maria Pia, ; Marta, Fumagalli
Pharmacological blockade of the P2Y-like GPR17 receptor with montelukast delays disease progression by counteracting oligodendrocyte dysfunction in the SOD1G93A mouse model of amyotrophic lateral sclerosis 1-gen-2022 Raffaele, Stefano; Nguyen, THI PHUONG NHUNG; Boccazzi, Marta; Frumento, Giulia; Milanese, Marco; Bonanno, Giambattista; Abbracchio Maria, Pia; Bonifacino, Tiziana; Fumagalli, Marta